A common side- or adverse effect from the drug affecting upp to 44% of the patients (PMID 19381453). Typically lymphocyte-rich. Sometimes chylous (PMIDĀ 19838099). Management guidelines at PMIDĀ 20375898

Last update : 14/05/2015
 

Media

No medias available.